K2 THERAPEUTICS Trademark

Trademark Overview

On Friday, February 28, 2025, a trademark application was filed for K2 THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the K2 THERAPEUTICS trademark a serial number of 99061027. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, August 8, 2025. This trademark is owned by K2 Therapeutics Pte. Ltd.. The K2 THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the prevention and treatment of disease, namely, cancer, autoimmune diseases and immunological diseases; therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases; pharmaceuticals being medicines comprised of small molecules, cell therapies, nucleic acids and biologics for treatment of cancer, autoimmune diseases and immunological diseases; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases, and for use in the fields of oncology, auto-immunity and immunology

Pharmaceutical research and development; scientific research and development; medical research; development in the field of medical products and preparations; medical research, development, manufacturing and commercialization services in the fields of drug discovery, oncology, auto-immunity and immunology; development of manufacturing methods for others for pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases, and for use in the fields of oncology, auto-immunity and immunology
k2 therapeutics

General Information

Serial Number99061027
Word MarkK2 THERAPEUTICS
Filing DateFriday, February 28, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateFriday, August 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkK TWO THERAPEUTICS
Goods and ServicesPharmaceutical products for the prevention and treatment of disease, namely, cancer, autoimmune diseases and immunological diseases; therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases; pharmaceuticals being medicines comprised of small molecules, cell therapies, nucleic acids and biologics for treatment of cancer, autoimmune diseases and immunological diseases; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases, and for use in the fields of oncology, auto-immunity and immunology
Pseudo MarkK TO THERAPEUTICS
NOT AVAILABLETHERAPEUTICS
Goods and ServicesPharmaceutical research and development; scientific research and development; medical research; development in the field of medical products and preparations; medical research, development, manufacturing and commercialization services in the fields of drug discovery, oncology, auto-immunity and immunology; development of manufacturing methods for others for pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer, autoimmune diseases and immunological diseases, and for use in the fields of oncology, auto-immunity and immunology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 28, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameK2 Therapeutics Pte. Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRepublic Plaza 048619
SG

Trademark Events

Event DateEvent Description
Friday, February 28, 2025NEW APPLICATION ENTERED
Friday, February 28, 2025APPLICATION FILING RECEIPT MAILED
Sunday, August 3, 2025ASSIGNED TO EXAMINER
Thursday, August 7, 2025NON-FINAL ACTION WRITTEN
Thursday, August 7, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 7, 2025NON-FINAL ACTION E-MAILED
Friday, August 8, 2025EXAMINERS AMENDMENT E-MAILED
Friday, August 8, 2025EXAMINER'S AMENDMENT ENTERED
Friday, August 8, 2025EXAMINERS AMENDMENT -WRITTEN
Friday, August 8, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 8, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 22, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

therapeutics diseases pharmaceuticals autoimmune development cancer immunological treatment research fields auto